Literature DB >> 8041622

Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.

C E Pritchard1, J A Grasby, F Hamy, A M Zacharek, M Singh, J Karn, M J Gait.   

Abstract

The HIV-1 regulatory proteins tat and rev are both RNA binding proteins which recognize sequences in duplex RNA which are close to structural distortions. Here we identify phosphate contacts which are critical for each binding reaction by use of a new method. Model RNA binding sites are constructed carrying substitutions of individual phosphodiesters by uncharged methylphosphonate derivatives isolated separately as Rp and Sp diastereoisomers and tested for protein binding by competition assays. In the binding of tat to the trans-activation response region (TAR), three phosphates, P21 and P22 which are adjacent to the U-rich bulge and P40 on the opposite strand, are essential and in each case both isomers inhibit binding. Similarly, in the interaction between the HIV-1 rev protein and the rev-responsive element (RRE) both methylphosphonate isomers at P103, P104, P124 and P125 interfere with rev binding. At P106, only the Rp methylphosphonate isomer is impaired in rev binding ability and it is proposed that the Rp oxygen is hydrogen-bonded to an uncharged amino acid or to a main chain hydrogen atom. Synthetic chemistry techniques also provide evidence for the conformations of non-Watson-Crick G106:G129 and G105:A131 base-pairs in the RRE 'bubble' structure upon rev binding. Almost all functional groups on the 5 bulged residues in the bubble have been ruled out as sites of contact with rev but, by contrast, the N7-positions of each G residue in the flanking base-pairs are identified as sites of likely hydrogen-bonding to rev. The results show that both tat and rev recognize the major groove of distorted RNA helixes and that both proteins make specific contacts with phosphates which are displaced from the sites of base-pair contact.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041622      PMCID: PMC308214          DOI: 10.1093/nar/22.13.2592

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.

Authors:  S Heaphy; C Dingwall; I Ernberg; M J Gait; S M Green; J Karn; A D Lowe; M Singh; M A Skinner
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

2.  Sequence-specific RNA binding by the HIV-1 Rev protein.

Authors:  M L Zapp; M R Green
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

3.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

4.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Authors:  M H Malim; L S Tiley; D F McCarn; J R Rusche; J Hauber; B R Cullen
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

6.  Methylphosphonates as probes of protein-nucleic acid interactions.

Authors:  S A Noble; E F Fisher; M H Caruthers
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

7.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

9.  Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.

Authors:  F Hamy; U Asseline; J Grasby; S Iwai; C Pritchard; G Slim; P J Butler; J Karn; M J Gait
Journal:  J Mol Biol       Date:  1993-03-05       Impact factor: 5.469

10.  Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.

Authors:  T J Daly; K S Cook; G S Gray; T E Maione; J R Rusche
Journal:  Nature       Date:  1989-12-14       Impact factor: 49.962

View more
  22 in total

1.  Molecular dynamics studies of the HIV-1 TAR and its complex with argininamide.

Authors:  R Nifosì; C M Reyes; P A Kollman
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

2.  Two crystal forms of helix II of Xenopus laevis 5S rRNA with a cytosine bulge.

Authors:  Y Xiong; M Sundaralingam
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Interactions of protein side chains with RNA defined with REDOR solid state NMR.

Authors:  Wei Huang; Gabriele Varani; Gary P Drobny
Journal:  J Biomol NMR       Date:  2011-09-25       Impact factor: 2.835

4.  A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation.

Authors:  J A Ippolito; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

5.  A thermodynamic analysis of the sequence-specific binding of RNA by bacteriophage MS2 coat protein.

Authors:  H E Johansson; D Dertinger; K A LeCuyer; L S Behlen; C H Greef; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

6.  TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer.

Authors:  A Garbesi; F Hamy; M Maffini; G Albrecht; T Klimkait
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

7.  An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.

Authors:  F Hamy; E R Felder; G Heizmann; J Lazdins; F Aboul-ela; G Varani; J Karn; T Klimkait
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

8.  Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands.

Authors:  K B Jensen; B L Atkinson; M C Willis; T H Koch; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  Identification of c-di-GMP derivatives resistant to an EAL domain phosphodiesterase.

Authors:  Carly A Shanahan; Barbara L Gaffney; Roger A Jones; Scott A Strobel
Journal:  Biochemistry       Date:  2013-01-03       Impact factor: 3.162

10.  Assignment and modeling of the Rev Response Element RNA bound to a Rev peptide using 13C-heteronuclear NMR.

Authors:  J L Battiste; R Tan; A D Frankel; J R Williamson
Journal:  J Biomol NMR       Date:  1995-12       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.